Guidelines for the Management of Pregnant Women With Substance Use Disorders.
Publication/Presentation Date
1-1-2016
Abstract
BACKGROUND: Women of reproductive potential with substance use disorders, especially those who are pregnant, present many clinical challenges to healthcare providers, including comorbid psychiatric disorders, a history of trauma and abuse, avoidance of or poor access to prenatal care, fear of legal consequences, and countertransference reactions.
METHODS: In November 2013, members of the Women's Mental Health Special Interest Group of the Academy of Psychosomatic Medicine presented a Workshop reviewing substance abuse in pregnancy, highlighting the specific contributions that psychosomatic medicine specialists can make in the care of these patients. The discussion focused on epidemiology; maternal and fetal risks; and screening and treatment considerations for tobacco, alcohol, cannabis, opioids, benzodiazepines, stimulants, and several other substances.
OBJECTIVE: Our purpose in publishing this review is to provide clinicians and educators with the most up-to-date summary in this field to better engage these patients in care and break the intergenerational cycle of abuse and addiction.
Volume
57
Issue
2
First Page
115
Last Page
130
ISSN
1545-7206
Published In/Presented At
McLafferty, L. P., Becker, M., Dresner, N., Meltzer-Brody, S., Gopalan, P., Glance, J., Victor, G. S., Mittal, L., Marshalek, P., Lander, L., & Worley, L. L. (2016). Guidelines for the Management of Pregnant Women With Substance Use Disorders. Psychosomatics, 57(2), 115–130. https://doi.org/10.1016/j.psym.2015.12.001
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
26880374
Department(s)
Administration and Leadership
Document Type
Article